entertainment -WSS

entertainment

author：knowledge 2025-09-30 17:04:22 - browse：9389

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： The 10 drugs up first for Medicare price negotiation

explore

hotspot

WSS

Listen: Biogen's potential pivot, & Illumina's next chapter

Ripples from Flovent's discontinuation is killing children with asthma

HHS suspends federal funding for EcoHealth Alliance

Humana sues Biden admin over Medicare Advantage audit rule

As H5N1 spreads in cows, experts warn against drinking raw milk

Stem cell treatment guidelines are released by FDA

Wikipedia

entertainment

hotspot

Moonlake's readout produced a cash windfall. Risks remain

What American doctors can learn from their Israeli counterparts

Walensky prepares to leave CDC — and Congress — behind

Trump surgeon general acknowledges mistakes during Covid

In age of alternative facts, a scholarly course on calling out crap

Fertility clinic egg and embryo storage is a disaster

Tori Bowie and the unacceptable rates of Black maternal death

The White House hikes tariffs on plastic syringes made in China

In Memoriam: Notable people who died in 2023

Free medical tuition alone isn't enough to close gaps in primary care

entertainment

NIH nominee Bertagnolli will get October confirmation hearing

Ripples from Flovent's discontinuation is killing children with asthma

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

A new House health package & hospitals’ new site

House transparency, PBM reform bill gains bipartisan support

HHS suspends federal funding for EcoHealth Alliance

explore

knowledge

hotspot

knowledge